Sorry, you need to enable JavaScript to visit this website.
Skip to main content
Home

Header Top Menu

  • Careers
  • Investors
  • News
    • Press Release Archive
    • Press Statements
    • Podcasts
      • The Antigen Podcast
      • Get Science Podcast
      • Diverse Perspectives Podcast
      • menopause: unmuted
      • Hemcast
    • Contact Media Relations
    • Press Kits & Downloads
      • Company Press Kit
      • Pfizer Oncology Press Kit
      • PSA Narrative
      • RA NarRAtive
      • Rare Disease Gene Therapy Press Kit
      • ATTR-Amyloidosis Press Kit
      • UC Narrative
      • Eczema Inside Out Press Kit
  • Partners
    • Discovery to Pre-candidate
      • Focus Areas
        • Therapeutic Areas
          • Internal Medicine
          • Inflammation and Immunology
          • Oncology
          • Rare Disease
          • Vaccines
        • Therapeutic Modalities and Technology Platforms
          • Drug Safety
          • Gene Therapy
          • Target Sciences
          • Precision Medicine
          • Medicinal Sciences
            • Biologics Product & Process Development
            • Biotherapeutics Discovery
            • Medicine Design
            • Small Molecule Product & Process Development
        • Emerging Science
          • DNA Damage Response
          • Microsatellite Repeat Expansions
          • Senescence
      • Partnering Models
    • Candidate Through Commercialization
      • Focus Areas
        • Internal Medicine
        • Inflammation and Immunology
        • Oncology
        • Rare Disease
        • Vaccines
        • Hospital
    • Pfizer CentreOne
    • Pfizer Ventures
      • Our portfolio

Healthcare Professionals

  • Healthcare Professionals

Connect with Us

  • Connect with Us
    • Email
    • FAQ
    • Privacy Policy (NEW)
    • YouTube
    • Twitter
    • Facebook
    • LinkedIn
    • Instagram
  • Your Health

    • Healthy Living
      • Brain & Nervous System
      • Cardiovascular Health
      • Cold & Flu
      • Digestive Health
      • Healthier Aging
      • Living Tobacco Free
      • Men’s Health
      • Mental Health
      • Nutrition & Fitness
      • Pediatric Health
      • Respiratory Health
      • Skin Health
      • Vaccines & Prevention
      • Women’s Health

    • Disease & Condition
      • Cancer
      • Cardiovascular Diseases & Conditions
      • Diabetes & Metabolic Disorders
      • Immune System Diseases & Conditions
      • Infections & Infectious Diseases
      • Neurological Diseases & Conditions
      • Menopause
      • Rare Disease
      • Vaccine-Related Conditions
      • Skin Diseases & Conditions
      • Atopic Dermatitis
      • Cardiovascular Disease
      • Severe Hypertriglyceridemia

    • Coronavirus disease (COVID-19) Resources

    • Managing your health
      • Caregiving
      • Evaluating Health Information
      • Tracking Your Health
      • Your Medicines
      • Health Literacy

    • Wellness
    Hot Topics

    Maintaining Emotional Well-Being During COVID-19

    Emotional Well-Being Tips for People Living with Chronic Inflammatory Conditions During COVID-19
  • Our Science

    • Driven to Discover the cure

    • Focus Areas
      • Internal Medicine
      • Inflammation & Immunology
      • Oncology
      • Rare Disease
      • Vaccines
      • Anti Infectives

    • Product Pipeline

    • Clinical Trials
      • Guide to Clinical Trials
      • Find a Trial
      • Expanded Access & Compassionate Use
      • Clinical Trials in Children
      • Partnering with Pfizer
      • Trial Data & Results
      • Research Integrity & Transparency
      • Diversity in Clinical Trials

    • R&D Platforms
      • Biosimilars
      • Gene Therapy
      • Medicinal Sciences
      • Precision Medicine
      • Maternal Immunization

    • Collaboration
      • Partner with Pfizer

    • Research sites

    • Coronavirus disease (COVID-19) Resources
      • All COVID-19 Updates
      • Vaccine Efforts
      • Antiviral Efforts
      • Partnerships & Anti-Infective Efforts
      • Supporting the Fight Against COVID-19
    HOT TOPICS

    MRNA VS. CONVENTIONAL VACCINES

    What Makes an RNA Vaccine Different From a Conventional Vaccine?
  • Our People

    • Meet The Experts
      • Scientists
      • Internal Medicine – Metabolic Disease
      • Inflammation & Immunology
      • Oncology
      • Rare Disease
      • Vaccines
      • Medical Professionals

    • The Journey

    • Leadership
      • Executives
      • Board Members
      • Company Fact Sheet

    • Diverse Perspectives
      • Diversity & Inclusion
      • Supplier Diversity
    HOT TOPICS

    Meet our new Chief Patient Officer, Dr. Dara Richardson-Heron

    dr_richardson_300x170.jpg

    Working Together to Empower Women

    VizagWomen_300x170.jpg

    • Hot Topics
  • Our Purpose

    • Commitment to Global Health
      • Expanding Access
      • Strengthening Health Systems
      • Providing Disaster & Humanitarian Relief
      • Unleashing the Power of Our Colleagues
      • Highlighting Individual Voices

    • Protecting People and the Environment
      • Pfizer's Green Journey
      • Product Stewardship
      • EHS Governance
      • EHS Supply Chain
      • Key Performance Indicators
      • Health & Safety
      • Human Rights

    • Positions on Health Policies
      • Ready for Cures
      • How does Pfizer price medicines?
      • Value of Medicines
      • Policy Positions
      • Creating Cures Through Facility Investments

    • Transparency
      • Working with Health Care Professionals
      • Transparency in Grants
      • Code of Conduct
      • Corporate Compliance
      • Sales and Marketing Compliance

    • Independent Grants
      • Competitive Grants Program
      • Independent Medical Education
      • Investigator Sponsored Research
      • Quality Improvement
      • COVID-19 Vaccine Grants

    • Contributions & Partnerships
      • Healthcare Charitable Contributions
      • Lobbying & Political Contributions
    HOT TOPICS

    Pfizer Women’s Resource Group

    Media Name: IWD_Pull_up_Banner_300x170.jpg

    • Hot Topics
  • Our Products

    • Product listing

    • How drugs are made
      • Branded vs. Generic
      • Biologics & Biosimilars
      • Commitment to Quality

    • Distributors
      • Pfizer Distributors
      • Greenstone Distributors

    • Medicine Safety
      • Reporting Adverse Events
      • Making Good Treatment Choices
      • Partnering With Patients
      • Health Literacy
      • Medicine Safety Tips for Patients
      • Counterfeiting
      • Unused Medicines

    • Safety Data Sheets

    • Medical Information Contacts

    • Pfizer Global Supply
    HOT TOPICS

    Universal vs. Single Payer Healthcare

    Media Name: universal_healthcare300x170.jpg
  • Careers

    • Working Here
      • Mission & Purpose
      • Culture
      • Diversity & Inclusion
      • Career Growth & Colleague Development
      • Compensation & Benefits
      • Ensuring Corporate Responsibility
    • Search Jobs
    • Student & Early Career
      • Postdoctoral Program
      • US Summer Student Worker Program
      • Opportunities for Veterans
    • Pfizer365.com
    • Our Hiring & Recruiting Process
      • Frequently Asked Questions
      • Tips for Interviewing at Pfizer
    • Connect With Us
  • Investors

    • Investors Overview
      • Why Invest / Our Story
      • Prospective Investors
      • Fact Sheet
    • Events & Presentations
    • Financials
      • Quarterly Reports
      • Annual Reports
      • SEC Filings
      • Interactive Data Filings
    • Investor News
    • Stock Information
      • Historical Price Lookup
      • Investment Calculator
      • Historical Stock Chart & Data
      • Dividend & Split History
      • Stock FAQs
    • Governance
      • Board Committees and Charters
      • The Pfizer Board Policies
      • Corporate Governance FAQs
      • Contact Our Directors
    • Shareholder Services
      • Stock FAQs
      • Advisory Information
      • Cost Basis Calculator
  • News

    • Contact Media Relations
    • Podcasts
    • Press Kits & Downloads
    • Press Release Archive
    • Press Statements
  • Partners
  • Footer links

    • Footer Aside Section1
      • CAREER-SEEKERS
      • INVESTORS
      • News & Media
      • Partners
    • Footer Aside Section 2
      • Healthcare Professionals
      • Business To Business
      • Change Region
      • Sitemap
    • Footer Aside Section3
      • Twitter
      • Facebook
      • Linkedin
      • Instagram
      • Youtube
    • Footer Aside Section4
      • Contact Us
      • Terms of Use
      • Privacy Policy

Partnering to Improve Health for All

Partnering to Improve Health for All
OUR PURPOSE/ Partnering to Improve Health for All
September 5, 2019

"Health for All” is at the core of our company’s purpose. We advance breakthroughs that change patients’ lives by ensuring they have access to quality healthcare services and Pfizer’s medicines and vaccines.

As we work to advance progress against the United Nations’ Sustainable Development Goal 3 (SDG3) — which aims to “ensure healthy lives and promote well-being for all at all ages” — we know that we must work differently to do more in the face of today’s unprecedented challenges to ensure all people have access to the quality health services they need.

“To make the shared vision of SDG3 a reality will require innovative partnerships, bold investments, and the capability to scale successes,” said Caroline Roan, Vice President, Global Health & Patient Access.

Nearly five years into the SDGs, great strides have been taken to improve the health of people around the world. As a core tenet of SDG3, universal health coverage (UHC) has become a global priority – it is a central component of the World Health Organization’s General Programme of Work 2019-2023, and has sparked the development of the Global Action Plan for Healthy Lives and Well-being for All to accelerate the necessary shift from siloed, disease-specific programs and investments to stronger health systems to improve health outcomes more generally. And this fall, it was center stage at the UN General Assembly as the first high-level meeting on UHC to help bolster global commitment took place.

Pfizer believes in the promise of UHC. We recognize that access to safe, effective, quality and affordable medicines and vaccines is a critical component of UHC and that, as an innovative pharmaceutical company, we have an important role to play in helping to deliver on this target.

For more than 160 years, Pfizer has made significant, far-reaching contributions to improving health around the world, helping to increase access to life-saving products and strengthen health systems to deliver for the most vulnerable people. But given the complexity of the global health landscape, there is no such thing as status quo. We must continually evolve our approach, finding new solutions that are not only transformative but also sustainable.

In order to promote health and well-being for all, we leverage the full extent of our resources – from our medicines and vaccines to our financial investments and our colleagues’ expertise – in areas and communities where we can have the greatest impact. Through innovative partnerships and programs,Pfizer and its partners are helping to drive progress in bold ways that support local communities by strengthening systems and increasing access to care:

  • The Global Health Innovation Grants program, which is managed by the Pfizer Foundation* in partnership with Innovations in Healthcare, has helped provide 370,000 new patients with care, 160,000 new patients with screening and education and 2,000 health workers with training. This year’s cohort includes 20 grantees focused on tackling critical health challenges related to infectious diseases, with each receiving $100,000 to support their work in low- and middle-income countries in Africa, Asia and Latin America.
  • Through the Pfizer Foundation* Healthy Families, Healthy Futures program, we have supported more than 121,000 women in five African countries through programs that integrate the delivery of childhood immunizations and family planning services, breaking down barriers to access and increasing efficiencies to maximize impact.
  • In partnership with the International Trachoma Initiative, we’ve donated more than 875 million doses of antibiotics to 40 countries to fight trachoma, a debilitating disease that is the leading infectious cause of blindness worldwide and results in up to $8 billion in lost productivity each year.
  • As a partner of Gavi, the Vaccine Alliance, we’ve helped to make pneumococcal conjugate vaccines available in some of the world’s poorest countries, which protects more than 29 million babies from pneumonia in Gavi-supported countries each year.
  • Through Pfizer RxPathways®, we have helped more than 679,000 patients receive over 9 million Pfizer prescriptions for free or at a savings in the last five years.
  • Through Accelerate2030, a nine-month capacity-building program with a mission to support and scale social ventures that contribute to the SDGs, we’ve helped to reach 2 million people with 80+ impact-driven ventures.
  • Since 2003, roughly 500 Pfizer colleagues have contributed their expertise to build capacity and strengthen healthcare delivery in low- and middle-income countries, working with 81 partner organizations in 50 nations through our Global Health Fellows and Global Health Teams.

There is no one path to universal health coverage – each country’s journey to achieving UHC will be driven by its unique historical, economic, political and social contexts. While UHC does not mean free coverage for all health interventions or a single-payer system, what it does mean is equitable access to a range of health services, from health promotion and prevention to treatment, rehabilitation and palliative care, without suffering financial hardship. It will require a multifaceted approach that addresses the interrelated components of service provision, health infrastructure and quality assurance in addition to sustainable financing. We’re proud of the efforts of our colleagues, partners, and peers to improve global health and ensure health for all, and we are committed to doing our part to continue to accelerate equitable and sustainable progress toward UHC.

Watch the video below to learn more about how we’re committed to creating a healthier world.

 

*The Pfizer Foundation is a charitable organization established by Pfizer Inc. It is a separate legal entity from Pfizer Inc. with distinct legal restrictions.

iUnited Nations (nd) Goal 3: Ensure healthy lives and promote well-being for all ages. Available at: https://www.un.org/sustainabledevelopment/health/ (Accessed: 23 April 2109).
iiWHO (2019) Universal Health Coverage. Available at: https://www.who.int/en/news-room/fact-sheets/detail/universal-health-coverage-(uhc) (Accessed: 23 April 2109).
iiiIbid.

Learn how Pfizer's innovative global health initiatives are helping to improve health for all.

Related Hot Topics
Albert Bourla Reflects on the One Year Anniversary of the COVID-19 Pandemic
Albert Bourla Reflects on the One Year Anniversary of the COVID-19 Pandemic
Albert Bourla On Ensuring Equitable Access to COVID-19 Vaccines
Albert Bourla On Ensuring Equitable Access to COVID-19 Vaccines
Advancing Health Equity & Social Justice Through Community Investment
Advancing Health Equity & Social Justice Through Community Investment
Why Your Family Health History Matters
Why Your Family Health History Matters
Chronic Stress and How to Manage It
Chronic Stress and How to Manage It
Shedding Light on Seasonal Affective Disorder
Shedding Light on Seasonal Affective Disorder
What is Ankylosing Spondylitis?
What is Ankylosing Spondylitis?
Pfizer_JonxPillemer_Kenya_2016-1355_380X200.jpg
The Pfizer Foundation Invests in Community-Based Solutions to Combat the Threat…
Tags
Access
Global Health Agenda
Healthcare
Individual Voices
Partnerships
Responsibility
Sustainable Development Goals
Show
Hide

Footer menu

  • Your Health
    • Healthy Living
    • Disease Conditions
    • Manage Your Health
  • Our Science
    • Therapeutic Areas
    • Product Pipeline
    • Clinical Trials
    • R&D Platforms
    • Collaboration
    • Research SItes
  • Our People
    • Meet the Experts
    • The Journey
    • Leadership
    • Diverse Perspectives
  • Our Purpose
    • Commitment To Global Health
    • Positions on Health Policies
    • Transparency
    • Contributions & Partnerships
  • Our Products
    • Product Listing
    • How Drugs are Made
    • Distributors
    • Global Product Information Contacts

Footer aside

  • Footer Aside Section1
    • CAREER-SEEKERS
    • INVESTORS
    • News & Media
    • Partners
  • Footer Aside Section 2
    • Healthcare Professionals
    • Business To Business
    • Change Region
    • Sitemap
  • Footer Aside Section3
    • Twitter
    • Facebook
    • Linkedin
    • Instagram
    • Youtube
  • Footer Aside Section4
    • Contact Us
    • Terms of Use
    • Privacy Policy
Pfizer Logo Footer

Copyright © 2002-2021 Pfizer Inc. All rights reserved. This information—including product information—is intended only for residents of the United States.
The products discussed herein may have different labeling in different countries.